PS.

NHS National Framework for Natalizumab-February 2024

NHS EnglandcontractFind a Tender ↗Ref ocds-h6vhtk-040f2f32014L0024active

Estimated value

—

goods

Awarded value

—

Suppliers

3

1 SME

Lots

1

3 awarded

Published

02 Feb 2024

Description

Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024<br/>Offer reference number: CM/PHR/22/5693<br/>Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Scope

Reference
CM/PHR/23/5701
Commercial tool
Standalone contract
Contract dates
01 Feb 2024 to 30 Apr 2025
Main category
goods
Contract locations
UK

Award criteria

Criteria the buyer will use to evaluate bids.

NameDescriptionTypeWeighting
——price—

Submission & procedure

Procedure
Open procedure

Award details· 3 awards

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

—

Award date

—

Contract start

—

Contract end

—

Awarded to
SB
Samsung Bioepis UK Ltd
SME
AP
Alexion Pharmaceuticals
AL
Amgen Ltd